Pharmaceuticals in Brazil
Summary
Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceutical market includes sales of both prescriptions and over-the-counter (OTC) drugs. The market scope does not cover consumer healthcare and animal health products.
- The Brazilian pharmaceuticals market recorded revenues of $27.1 billion in 2024, representing a compound annual growth rate (CAGR) of 2.8% between 2019 and 2024.
- The oncology drugs segment accounted for the market's largest proportion in 2024, with total revenues of $4.0 billion, equivalent to 14.7% of the market's overall value.
- The Brazilian pharmaceuticals market witnessed healthy growth in 2024, registering an annual growth of 6.3%.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Brazil
- Leading company profiles reveal details of key pharmaceuticals market players? global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil pharmaceuticals market with five year forecasts
- What was the size of the Brazil pharmaceuticals market by value in 2024?
- What will be the size of the Brazil pharmaceuticals market in 2029?
- What factors are affecting the strength of competition in the Brazil pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up Brazil's pharmaceuticals market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 COMPANY PROFILES
8.1. Ache Laboratorios Farmaceuticos SA
8.2. EMS SA
8.3. Hypera SA
8.4. Eurofarma Laboratorios SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
4 MARKET SEGMENTATION
4.1. Category segmentation
4.2. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. What are the recent developments in the market?
8 COMPANY PROFILES
8.1. Ache Laboratorios Farmaceuticos SA
8.2. EMS SA
8.3. Hypera SA
8.4. Eurofarma Laboratorios SA
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Brazil pharmaceuticals market value: $ million, 2019-24
Table 2: Brazil pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Brazil pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Ache Laboratorios Farmaceuticos SA: Key Facts
Table 7: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 8: EMS SA: Key Facts
Table 9: Hypera SA: Key Facts
Table 10: Hypera SA: Annual Financial Ratios
Table 11: Hypera SA: Key Employees
Table 12: Eurofarma Laboratorios SA: Key Facts
Table 13: Eurofarma Laboratorios SA: Key Employees
Table 14: Brazil Size of Population (Million), 2020-24
Table 15: Brazil Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 16: Brazil GDP (Current Prices, $ Billion), 2020-24
Table 17: Brazil Inflation, 2020-24
Table 18: Brazil Consumer Price Index (Absolute), 2020-24
Table 19: Brazil Exchange Rate, 2019-24
Table 1: Brazil pharmaceuticals market value: $ million, 2019-24
Table 2: Brazil pharmaceuticals market category segmentation: % share, by value, 2019-24
Table 3: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Table 4: Brazil pharmaceuticals market geography segmentation: $ million, 2024
Table 5: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Table 6: Ache Laboratorios Farmaceuticos SA: Key Facts
Table 7: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 8: EMS SA: Key Facts
Table 9: Hypera SA: Key Facts
Table 10: Hypera SA: Annual Financial Ratios
Table 11: Hypera SA: Key Employees
Table 12: Eurofarma Laboratorios SA: Key Facts
Table 13: Eurofarma Laboratorios SA: Key Employees
Table 14: Brazil Size of Population (Million), 2020-24
Table 15: Brazil Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 16: Brazil GDP (Current Prices, $ Billion), 2020-24
Table 17: Brazil Inflation, 2020-24
Table 18: Brazil Consumer Price Index (Absolute), 2020-24
Table 19: Brazil Exchange Rate, 2019-24
LIST OF FIGURES
Figure 1: Brazil pharmaceuticals market value: $ million, 2019-24
Figure 2: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Brazil pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in Brazil, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in Brazil, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in Brazil, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2024
Figure 1: Brazil pharmaceuticals market value: $ million, 2019-24
Figure 2: Brazil pharmaceuticals market category segmentation: $ million, 2019-24
Figure 3: Brazil pharmaceuticals market geography segmentation: % share, by value, 2024
Figure 4: Brazil pharmaceuticals market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the pharmaceuticals market in Brazil, 2024
Figure 6: Drivers of buyer power in the pharmaceuticals market in Brazil, 2024
Figure 7: Drivers of supplier power in the pharmaceuticals market in Brazil, 2024
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2024
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2024
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2024
